The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies ...

The Trump administration wants to update warning labels on testosterone replacement therapies, saying newer evidence does not ...

The 2015 warnings were added because concerns about heart risks were raised, plus evidence of benefits were “limited” at the ...

HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical ...

FDA is removing warning labels from testosterone replacement therapy, or TRT, as a key advancement of men's health.

But on June 18, the U.S. Department of Health and Human Services (HHS) announced that it is requesting updates to ...

The U.S. Department of Health and Human Services wants to remove some of the stigma from testosterone treatment.

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after ...

Two recent studies suggest that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal ...

A lot of men live with treatable health issues for far longer than they should. Usually, it is not because nothing can be ...

In this study, researchers aimed to determine whether adding apalutamide to ADT improves outcomes in high-risk prostate cancer compared to placebo plus ADT.

GLP-1 drugs male fertility research presented at ENDO 2026 finds Ozempic-class medications do not harm male hormones and may ...